Kenvue Inc. (NYSE:KVUE) Shares Bought by D.A. Davidson & CO.

D.A. Davidson & CO. raised its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 305.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 157,247 shares of the company's stock after buying an additional 118,510 shares during the period. D.A. Davidson & CO.'s holdings in Kenvue were worth $3,357,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in KVUE. AMF Tjanstepension AB increased its stake in shares of Kenvue by 187.3% in the third quarter. AMF Tjanstepension AB now owns 120,477 shares of the company's stock worth $2,787,000 after purchasing an additional 78,540 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in Kenvue by 6.2% during the third quarter. Sequoia Financial Advisors LLC now owns 24,690 shares of the company's stock valued at $571,000 after purchasing an additional 1,449 shares during the last quarter. Signaturefd LLC raised its stake in shares of Kenvue by 394.0% in the third quarter. Signaturefd LLC now owns 4,061 shares of the company's stock valued at $94,000 after acquiring an additional 3,239 shares during the period. Commerzbank Aktiengesellschaft FI purchased a new stake in shares of Kenvue in the third quarter valued at $292,000. Finally, International Assets Investment Management LLC raised its stake in shares of Kenvue by 1,529.5% in the third quarter. International Assets Investment Management LLC now owns 106,341 shares of the company's stock valued at $2,460,000 after acquiring an additional 99,815 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

KVUE has been the topic of several recent analyst reports. UBS Group reduced their target price on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Piper Sandler raised shares of Kenvue from a "neutral" rating to an "overweight" rating and raised their price target for the stock from $21.00 to $26.00 in a research note on Monday, January 6th. Canaccord Genuity Group reduced their price target on shares of Kenvue from $27.00 to $24.00 and set a "buy" rating on the stock in a research note on Friday, February 7th. Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a "buy" rating to a "hold" rating and reduced their price target for the stock from $25.00 to $24.00 in a research note on Thursday, December 12th. Finally, Citigroup reduced their price target on shares of Kenvue from $25.00 to $21.00 and set a "neutral" rating on the stock in a research note on Wednesday, January 15th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $23.00.

Kenvue Stock Up 4.1 %

NYSE KVUE traded up $0.92 during trading on Friday, reaching $23.31. 25,659,098 shares of the company's stock traded hands, compared to its average volume of 13,792,800. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The firm has a market cap of $44.68 billion, a price-to-earnings ratio of 43.97, a price-to-earnings-growth ratio of 2.61 and a beta of 1.45. The company's 50 day simple moving average is $21.29 and its two-hundred day simple moving average is $22.14. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, meeting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.52%. The ex-dividend date of this dividend is Wednesday, February 12th. Kenvue's dividend payout ratio is currently 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.